Liquidia Corp (LQDA)

$22.43 +0.53 (2.42%)
Market Cap 1.93B
Revenue (ttm) 14.00M
Net Income (ttm) -130.39M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -931.36%
Debt to Equity Ratio 12.75
Volume 1,676,300
Avg Vol 2,908,986
Day's Range N/A - N/A
Shares Out 86.09M
Stochastic %K 37%
Beta 0.15
Analysts Strong Sell
Price Target $36.70

Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneou...

Industry: Biotechnology
Sector: Healthcare
Phone: 919 328 4400
Fax: 919 328 4402
Address:
419 Davis Drive, Suite 100, Morrisville, United States
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 5 at 3:47 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $LQDA Current Share Price: $22.43 Contracts: $LQDA October 16, 2026 $22 Calls Scale in: $8.44- $10.31 Scale out: $13.12-$16.88 Can Easily Capture: 60% ROI Blended DTE: 378 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
highnihilism
highnihilism Oct. 3 at 5:37 PM
$AMKR Amkor Technology Trades: 320 | Total $: 418.4 K | 1.33 × 90-Day Avg $: 315.5 K | Call $: 389 K | Put $: 29.4 K | Single-Leg: 99% | Multi-Leg: 1% $M Macy’s Trades: 788 | Total $: 535 K | 0.33 × 90-Day Avg $: 1.61 M | Call $: 388.7 K | Put $: 146.3 K | Single-Leg: 79% | Multi-Leg: 21% $TJX TJX Companies Trades: 638 | Total $: 1.11 M | 0.39 × 90-Day Avg $: 2.85 M | Call $: 385.4 K | Put $: 721.4 K | Single-Leg: 92% | Multi-Leg: 8% $LQDA Liquidia Trades: 183 | Total $: 449.8 K | 0.16 × 90-Day Avg $: 2.82 M | Call $: 384.7 K | Put $: 65.1 K | Single-Leg: 98% | Multi-Leg: 2%
0 · Reply
SweepCastApp
SweepCastApp Oct. 3 at 4:24 AM
$LQDA: Unusual Options Activity Alerted PUT flow observed 350x contracts at Strike price of $20 Exp on 10/17/2025 with Premium of $37K and showing BULLISH Sentiment
0 · Reply
ElliottwaveForecast
ElliottwaveForecast Oct. 3 at 1:27 AM
$LQDA 📊 $LQDA completed wave I at 29.94 and is now correcting wave II in 3, 7, or 11 swings. As long as dips hold above the 11.85 low, the bullish structure remains intact—another rally may be on deck. 👀 A potential buy setup could unfold soon.
0 · Reply
ElliottwaveForecast
ElliottwaveForecast Oct. 3 at 1:26 AM
Most traders wait for confirmation. We forecast it. $LQDA eyes rally in ((5)) of I—break above 28.98 could seal the wave before a pullback begins. Learn the Elliott Wave setup 👉 https://elliottwave-forecast.com/stock-market/liquidia-lqda-bullish-sequence-eyes-28-98-next-pullback/ #ElliottWave #Stocks #Biotech #TradingSignals #MarketForecast
0 · Reply
heyupikachu1821
heyupikachu1821 Oct. 2 at 8:17 PM
$LQDA $SRPT $SLNO $ABEO $MLTX These are all at extreme lows that I whole heartedly believe they will bounce back from Each has dropped for its own reason. Each comes with its own risk. Each will likely take time to recover But at these prices, the risk / reward is worth considering if you have the patience to go for a longer-term swing
0 · Reply
SteelerJon
SteelerJon Oct. 2 at 5:58 PM
$LQDA Stay positive….nothing a great ER won’t fix! It’s a mover….you know it..I know it. Hold long!😎🏦🏦
0 · Reply
TKkamen
TKkamen Oct. 2 at 5:28 PM
$LQDA Not sure what’s going on…
0 · Reply
jlonards
jlonards Oct. 2 at 5:17 PM
$LQDA ooops
0 · Reply
Trendrebel
Trendrebel Oct. 2 at 3:06 PM
$LQDA Looks more and more like 20.11 before Any reversal....maybe
0 · Reply
Latest News on LQDA
Liquidia Corporation to Present at the 2025 Wells Fargo Healthcare Conference

Aug 27, 2025, 8:30 AM EDT - 5 weeks ago

Liquidia Corporation to Present at the 2025 Wells Fargo Healthcare Conference

Liquidia Analysts Raise Their Forecasts Following Q2 Results

Aug 13, 2025, 2:51 PM EDT - 7 weeks ago

Liquidia Analysts Raise Their Forecasts Following Q2 Results

Why Is Liquidia Stock Trading Higher On Tuesday?

Aug 12, 2025, 2:25 PM EDT - 7 weeks ago

Why Is Liquidia Stock Trading Higher On Tuesday?

Liquidia Corporation (LQDA) Q2 2025 Earnings Call Transcript

Aug 12, 2025, 12:43 PM EDT - 7 weeks ago

Liquidia Corporation (LQDA) Q2 2025 Earnings Call Transcript

Liquidia Corporation Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Aug 12, 2025, 6:30 AM EDT - 7 weeks ago

Liquidia Corporation Reports Second Quarter 2025 Financial Results and Provides Corporate Update

What Next For Liquidia After Launch?

Jun 30, 2025, 10:40 AM EDT - 3 months ago

What Next For Liquidia After Launch?

Liquidia Receives $50 Million from Healthcare Royalty (HCRx) Following First Commercial Sale of YUTREPIA™

Jun 23, 2025, 4:34 PM EDT - 3 months ago

Liquidia Receives $50 Million from Healthcare Royalty (HCRx) Following First Commercial Sale of YUTREPIA™

Liquidia Schedules First Commercial Shipment of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with PAH and PH-ILD

Jun 2, 2025, 6:30 AM EDT - 4 months ago

Liquidia Schedules First Commercial Shipment of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with PAH and PH-ILD

These Analysts Boost Their Forecasts On Liquidia

May 28, 2025, 11:08 AM EDT - 4 months ago

These Analysts Boost Their Forecasts On Liquidia

Liquidia Corporation to Present at the 2025 Jefferies Global Healthcare Conference

May 28, 2025, 8:00 AM EDT - 4 months ago

Liquidia Corporation to Present at the 2025 Jefferies Global Healthcare Conference

U.S. FDA Approves Liquidia's YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

May 23, 2025, 2:28 PM EDT - 4 months ago

U.S. FDA Approves Liquidia's YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

Liquidia Corporation Provides Update on Litigation Filed by United Therapeutics

May 12, 2025, 6:00 AM EDT - 5 months ago

Liquidia Corporation Provides Update on Litigation Filed by United Therapeutics

Liquidia Corporation (LQDA) Q1 2025 Earnings Call Transcript

May 10, 2025, 9:29 PM EDT - 5 months ago

Liquidia Corporation (LQDA) Q1 2025 Earnings Call Transcript

Liquidia Corporation Reports First Quarter 2025 Financial Results and Provides Corporate Update

May 8, 2025, 6:30 AM EDT - 5 months ago

Liquidia Corporation Reports First Quarter 2025 Financial Results and Provides Corporate Update

Liquidia Corporation: A Strong Buy On High Likelihood Of FDA Approval This Month

May 5, 2025, 4:06 PM EDT - 5 months ago

Liquidia Corporation: A Strong Buy On High Likelihood Of FDA Approval This Month

District Court Dismisses Dispute Filed by United Therapeutics Against Liquidia

May 2, 2025, 5:28 PM EDT - 5 months ago

District Court Dismisses Dispute Filed by United Therapeutics Against Liquidia

Liquidia Corporation to Report First Quarter 2025 Financial Results on May 8, 2025

May 1, 2025, 8:00 AM EDT - 5 months ago

Liquidia Corporation to Report First Quarter 2025 Financial Results on May 8, 2025

Arquitos Capital's Largest Holdings  For Q1 2025

Apr 30, 2025, 9:30 AM EDT - 5 months ago

Arquitos Capital's Largest Holdings  For Q1 2025

UPDATE – Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

Apr 1, 2025, 10:33 AM EDT - 6 months ago

UPDATE – Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

Apr 1, 2025, 8:00 AM EDT - 6 months ago

Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

Liquidia Corporation Announces FDA Acceptance of New Drug Application Resubmission for YUTREPIA™ (treprostinil) Inhalation Powder

Mar 28, 2025, 9:30 AM EDT - 6 months ago

Liquidia Corporation Announces FDA Acceptance of New Drug Application Resubmission for YUTREPIA™ (treprostinil) Inhalation Powder

Liquidia Corporation (LQDA) Q4 2024 Earnings Call Transcript

Mar 19, 2025, 11:56 AM EDT - 7 months ago

Liquidia Corporation (LQDA) Q4 2024 Earnings Call Transcript

Liquidia Corporation Reports Full Year 2024 Financial Results and Provides Corporate Update

Mar 19, 2025, 6:30 AM EDT - 7 months ago

Liquidia Corporation Reports Full Year 2024 Financial Results and Provides Corporate Update

Liquidia Corporation to Report Full Year 2024 Financial Results on March 19, 2025

Mar 12, 2025, 8:00 AM EDT - 7 months ago

Liquidia Corporation to Report Full Year 2024 Financial Results on March 19, 2025

Liquidia Corporation: Resilience In The Face Of Formidable Opposition Can Pay Off

Nov 15, 2024, 10:20 AM EST - 11 months ago

Liquidia Corporation: Resilience In The Face Of Formidable Opposition Can Pay Off

Liquidia Corporation (LQDA) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 2:40 PM EST - 11 months ago

Liquidia Corporation (LQDA) Q3 2024 Earnings Call Transcript

Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Nov 13, 2024, 6:30 AM EST - 11 months ago

Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate Update

United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics' Patent

Oct 7, 2024, 10:00 AM EDT - 1 year ago

United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics' Patent

Liquidia and Pharmosa Biopharm Expand Collaboration to Develop Sustained Release Inhaled Treprostinil (L606)

Oct 2, 2024, 6:00 AM EDT - 1 year ago

Liquidia and Pharmosa Biopharm Expand Collaboration to Develop Sustained Release Inhaled Treprostinil (L606)

Liquidia Corporation Is Being Sued For Violating Securities Laws And Affected Investors Are Invited To Help The Schall Law Firm

Oct 1, 2024, 11:00 AM EDT - 1 year ago

Liquidia Corporation Is Being Sued For Violating Securities Laws And Affected Investors Are Invited To Help The Schall Law Firm

Liquidia Corporation Is Being Investigated For Violating Securities Laws And Impacted Investors Are Encouraged To Contact The Schall Law Firm

Sep 30, 2024, 11:00 AM EDT - 1 year ago

Liquidia Corporation Is Being Investigated For Violating Securities Laws And Impacted Investors Are Encouraged To Contact The Schall Law Firm

Liquidia Announces Poster Presentation and Medical Theater at the CHEST 2024 Annual Meeting

Sep 30, 2024, 8:00 AM EDT - 1 year ago

Liquidia Announces Poster Presentation and Medical Theater at the CHEST 2024 Annual Meeting

The Schall Law Firm Urges Shareholder Participation In A Securities Fraud Inquiry Into Liquidia Corporation

Sep 29, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Urges Shareholder Participation In A Securities Fraud Inquiry Into Liquidia Corporation

Liquidia Corporation Is Being Investigated For Violating Securities Laws And Investors Are Invited To Contact The Schall Law Firm

Sep 28, 2024, 11:00 AM EDT - 1 year ago

Liquidia Corporation Is Being Investigated For Violating Securities Laws And Investors Are Invited To Contact The Schall Law Firm

Investors Are Invited To Help The Schall Law Firm Investigate Whether Liquidia Corporation Violated Securities Laws

Sep 24, 2024, 11:00 AM EDT - 1 year ago

Investors Are Invited To Help The Schall Law Firm Investigate Whether Liquidia Corporation Violated Securities Laws

The Schall Law Firm Is Looking Into Liquidia Corporation For Securities Fraud And Shareholders With Losses Should Reach Out

Sep 23, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Is Looking Into Liquidia Corporation For Securities Fraud And Shareholders With Losses Should Reach Out

Liquidia Corporation May Have Defrauded The Public And The Schall Law Firm Wants Shareholders With Losses To Reach Out

Sep 21, 2024, 11:00 AM EDT - 1 year ago

Liquidia Corporation May Have Defrauded The Public And The Schall Law Firm Wants Shareholders With Losses To Reach Out

The Schall Law Firm Has Launched An Inquiry Into Liquidia Corporation For Violating Securities Laws And Affected Investors Should Participate

Sep 20, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Has Launched An Inquiry Into Liquidia Corporation For Violating Securities Laws And Affected Investors Should Participate

Liquidia Corporation Is Being Investigated For Securities Fraud And Shareholders With Losses Are Urged To Reach Out To The Schall Law Firm

Sep 19, 2024, 11:00 AM EDT - 1 year ago

Liquidia Corporation Is Being Investigated For Securities Fraud And Shareholders With Losses Are Urged To Reach Out To The Schall Law Firm

The Schall Law Firm Invites Investors To Join An Inquiry Into Liquidia Corporation For Violating Securities Laws

Sep 18, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Invites Investors To Join An Inquiry Into Liquidia Corporation For Violating Securities Laws

Liquidia Corporation Is Being Investigated For Securities Fraud And Affected Stakeholders Are Urged To Reach Out To The Schall Law Firm

Sep 17, 2024, 11:00 AM EDT - 1 year ago

Liquidia Corporation Is Being Investigated For Securities Fraud And Affected Stakeholders Are Urged To Reach Out To The Schall Law Firm

Court Finds United Therapeutics' Interference with Launch of Generic Treprostinil Injection Caused Losses of More Than $137 Million

Sep 16, 2024, 9:41 AM EDT - 1 year ago

Court Finds United Therapeutics' Interference with Launch of Generic Treprostinil Injection Caused Losses of More Than $137 Million

Liquidia Corporation May Have Engaged In Securities Fraud And Investors Are Urged To Join The Schall Law Firm's Investigation

Sep 15, 2024, 11:00 AM EDT - 1 year ago

Liquidia Corporation May Have Engaged In Securities Fraud And Investors Are Urged To Join The Schall Law Firm's Investigation

The Schall Law Firm Is Inquiring Into Liquidia Corporation's Questionable Practices And Shareholders Should Reach Out

Sep 14, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Is Inquiring Into Liquidia Corporation's Questionable Practices And Shareholders Should Reach Out

LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 5 at 3:47 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $LQDA Current Share Price: $22.43 Contracts: $LQDA October 16, 2026 $22 Calls Scale in: $8.44- $10.31 Scale out: $13.12-$16.88 Can Easily Capture: 60% ROI Blended DTE: 378 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
highnihilism
highnihilism Oct. 3 at 5:37 PM
$AMKR Amkor Technology Trades: 320 | Total $: 418.4 K | 1.33 × 90-Day Avg $: 315.5 K | Call $: 389 K | Put $: 29.4 K | Single-Leg: 99% | Multi-Leg: 1% $M Macy’s Trades: 788 | Total $: 535 K | 0.33 × 90-Day Avg $: 1.61 M | Call $: 388.7 K | Put $: 146.3 K | Single-Leg: 79% | Multi-Leg: 21% $TJX TJX Companies Trades: 638 | Total $: 1.11 M | 0.39 × 90-Day Avg $: 2.85 M | Call $: 385.4 K | Put $: 721.4 K | Single-Leg: 92% | Multi-Leg: 8% $LQDA Liquidia Trades: 183 | Total $: 449.8 K | 0.16 × 90-Day Avg $: 2.82 M | Call $: 384.7 K | Put $: 65.1 K | Single-Leg: 98% | Multi-Leg: 2%
0 · Reply
SweepCastApp
SweepCastApp Oct. 3 at 4:24 AM
$LQDA: Unusual Options Activity Alerted PUT flow observed 350x contracts at Strike price of $20 Exp on 10/17/2025 with Premium of $37K and showing BULLISH Sentiment
0 · Reply
ElliottwaveForecast
ElliottwaveForecast Oct. 3 at 1:27 AM
$LQDA 📊 $LQDA completed wave I at 29.94 and is now correcting wave II in 3, 7, or 11 swings. As long as dips hold above the 11.85 low, the bullish structure remains intact—another rally may be on deck. 👀 A potential buy setup could unfold soon.
0 · Reply
ElliottwaveForecast
ElliottwaveForecast Oct. 3 at 1:26 AM
Most traders wait for confirmation. We forecast it. $LQDA eyes rally in ((5)) of I—break above 28.98 could seal the wave before a pullback begins. Learn the Elliott Wave setup 👉 https://elliottwave-forecast.com/stock-market/liquidia-lqda-bullish-sequence-eyes-28-98-next-pullback/ #ElliottWave #Stocks #Biotech #TradingSignals #MarketForecast
0 · Reply
heyupikachu1821
heyupikachu1821 Oct. 2 at 8:17 PM
$LQDA $SRPT $SLNO $ABEO $MLTX These are all at extreme lows that I whole heartedly believe they will bounce back from Each has dropped for its own reason. Each comes with its own risk. Each will likely take time to recover But at these prices, the risk / reward is worth considering if you have the patience to go for a longer-term swing
0 · Reply
SteelerJon
SteelerJon Oct. 2 at 5:58 PM
$LQDA Stay positive….nothing a great ER won’t fix! It’s a mover….you know it..I know it. Hold long!😎🏦🏦
0 · Reply
TKkamen
TKkamen Oct. 2 at 5:28 PM
$LQDA Not sure what’s going on…
0 · Reply
jlonards
jlonards Oct. 2 at 5:17 PM
$LQDA ooops
0 · Reply
Trendrebel
Trendrebel Oct. 2 at 3:06 PM
$LQDA Looks more and more like 20.11 before Any reversal....maybe
0 · Reply
Quantumup
Quantumup Oct. 2 at 2:09 PM
TD Cowen⬆️the PT on $INSM to $193 from $154 and reiterated at a Buy rating after INSM presented its impressive Ph2 PAH data with TPIP as late breaker at ERS. $LQDA $UTHR TD Cowen said: 2° EPs show TPIP improved hemodynamic parameters, suggesting favorable impacts on heart fxn and supports the pulmonary selectivity of TPIP. Topline data was also reviewed: stat sig 35% PVR rdxn, stat sig 35.5m 6MWD improvement, and stat sig 60% NT-proBNP rdxn. A TPIP Ph3 PAH trial should initiate in early 2026.
0 · Reply
ElliottwaveForecast
ElliottwaveForecast Oct. 2 at 6:19 AM
📊 $LQDA completed wave I at 29.94 and is now correcting wave II in 3, 7, or 11 swings. As long as dips hold above the 11.85 low, the bullish structure remains intact—another rally may be on deck. 👀 A potential buy setup could unfold soon.
0 · Reply
ElliottwaveForecast
ElliottwaveForecast Oct. 2 at 5:51 AM
Most traders wait for confirmation. We forecast it. $LQDA eyes rally in ((5)) of I—break above 28.98 could seal the wave before a pullback begins. Learn the Elliott Wave setup 👉 https://elliottwave-forecast.com/stock-market/liquidia-lqda-bullish-sequence-eyes-28-98-next-pullback/ #ElliottWave #Stocks #Biotech #TradingSignals #MarketForecast
0 · Reply
SweepCastApp
SweepCastApp Oct. 1 at 11:47 PM
$LQDA: Unusual Options Activity Alerted CALL flow observed 50x contracts at Strike price of $25 Exp on 04/17/2026 with Premium of $34K and showing BULLISH Sentiment
0 · Reply
clan
clan Oct. 1 at 3:11 PM
$MNKD $UTHR IPF domination is coming for Tyvaso DPI. 😢 $LQDA 😭
2 · Reply
ElliottwaveForecast
ElliottwaveForecast Oct. 1 at 3:30 AM
📈 $LQDA has wrapped up wave I at 29.94 and is now correcting wave II in 3, 7, or 11 swings. As long as price action holds above the 11.85 low, the bullish structure stays intact—setting the stage for a potential rally. 🔥 Eyes on a promising buy setup forming soon! #LQDA #ElliottWave #StockMarket #TradingStrategy #MarketInsights
0 · Reply
ElliottwaveForecast
ElliottwaveForecast Oct. 1 at 3:28 AM
Most traders wait for confirmation. We forecast it. $LQDA eyes rally in ((5)) of I—break above 28.98 could seal the wave before a pullback begins. Learn the Elliott Wave setup 👉 https://elliottwave-forecast.com/stock-market/liquidia-lqda-bullish-sequence-eyes-28-98-next-pullback/ #ElliottWave #Stocks #Biotech #TradingSignals #MarketForecast
0 · Reply
Night_Owl_Biotech
Night_Owl_Biotech Oct. 1 at 2:10 AM
The XBI was up 21% in Q32025. The attachment notes the change in share price during the quarter for all 33 commercial-stage oncology focused bios versus all 33 in non-oncology with market caps between $1.5 & $5.0B as of the end of the quarter. It is not a perfect comparison because there are way more commercial-stage non-oncology focused bios. Note exactly 2/3s in each peer group were higher in the quarter. $CHRS & VSTM were the 2 biggest winners in the quarter in oncology. $LQDA was the winner in non-oncology. $VCEL & $TWST were the 2 biggest losers in non-oncology. Interestingly, VCEL is still one the best performing stocks in the peer group since their first FDA approval. $PGEN was the best performing in commercial-stage bio up 156% (though new in the quarter). If anyone can tell us which peer group (oncology or non) to which PGEN belongs, we'd appreciate the perspective. We assume oncology but... This is for entertainment purposes only. This is not investment advice.
0 · Reply
Zentech909
Zentech909 Oct. 1 at 1:33 AM
$LQDA when is company sharing ph3 results? Anytime soon?
2 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Sep. 30 at 9:47 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $LQDA Current Share Price: $22.42 Contracts: $LQDA October 16, 2026 $22 Calls Scale in: $8.17- $9.98 Scale out: $12.70-$16.34 Can Easily Capture: 60% ROI Blended DTE: 382 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
heyupikachu1821
heyupikachu1821 Sep. 30 at 8:02 PM
$LQDA Liquidia… you tease!
0 · Reply
SteelerJon
SteelerJon Sep. 30 at 6:24 PM
$LQDA Nothing matters daily…proof at ER. Solid moves made off ER news…😎🏦🏦 Hold tight…it’s coming…stay
0 · Reply